23 studies found for:    Progressive Multifocal Leukoencephalopathy
Show Display Options
Rank Status Study
21 Completed Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
Conditions: Multiple Sclerosis;   Relapse
22 Completed Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
Condition: Multiple Sclerosis
23 Active, not recruiting Drug Exposure Registry for GSK2248761, an Investigational NNRTI
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK2248761

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-23) Next Page   
Indicates status has not been verified in more than two years